Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and BCNU for Anaplastic Gliomas
NCT00003176Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Mar 1998
- Primary completion
- Dec 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide, carmustine in glioblastoma (GBM), anaplastic astrocytoma (AA), anaplastic oligoastrocytoma (AOA), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Mar 1998; status: completed.
02
Drugs
temozolomidecarmustine
03
Conditions
glioblastoma (GBM)anaplastic astrocytoma (AA)anaplastic oligoastrocytoma (AOA)
Beyond the preview
Go deeper on NCT00003176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003176.